Bremelanotide becomes the second FDA-approved drug for hypoactive sexual desire disorder in premenopausal women. It is self-injected at least 45 minutes before sexual activity. News Alerts …read more
A lawsuit has been filed against a UCLA gynecologic oncologist who is also facing criminal charges for sexual assault. Medscape Medical News …read more
A frequent flyer has taken care of ill passengers repeatedly on flights, but this time it had an unusual ending. Medscape Medical News …read more
The CDC has issued new skin testing recommendations in response to the anticipated nationwide shortage of the Aplisol tuberculin skin test. Medscape Medical News …read more
If you have reproductive-aged women in your practice, you’ve probably encountered perinatal depression–a common, treatable, and often serious condition. Medscape Ob/Gyn …read more
An expert in perinatal psychopharmacology describes how this novel drug works in the management of postpartum depression, and the challenges posed by its safety requirements. Medscape Ob/Gyn …read more
The risk for cancer in children born after assisted reproduction is assessed in a large study. Medscape Ob/Gyn …read more
New research confirms that women who have undergone breast cancer therapy are more at risk of cardiovascular disease, and it also shows why this may be. …read more
A California physician surrendered his license after prescribing drugs with only the patient information from an online questionnaire, and there are still ‘unanswered questions’ about regulation. Medscape Medical News …read more
Osteoporosis drugs appear to help women older than 80 years with multiple morbidities and osteoporosis; very elderly women with high fracture risk but no osteoporosis may benefit less, a study found. Medscape Medical News …read more